VCEL · Vericel Corp
Market Cap
$2.07B
Shares
51.21M
VCEL metrics
77 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$40.19
Market cap
$2.07B
Price action
19 metricsPrice change (1W)
-1.9%
Price change (30D)
-10.2%
Price change (3M)
+10.7%
Price change (6M)
+19.2%
Price change (YTD)
+11.6%
Price change (1Y)
+19.4%
Trailing year
Price change (5Y)
-28.7%
52-week high
$48.31
52-week low
$29.34
Change from 52-week high
-16.8%
Change from 52-week low
+37.0%
Annualized volatility
44.5%
Beta
0.9
RSI (14D)
35.6
Price vs SMA 50
-10.1%
Price vs SMA 200
+5.3%
Avg volume (3M)
563,210
Relative volume
0.6
Average dollar volume
$24.46M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
51.21M
Valuation
12 metricsP / E (TTM)
83.7
Trailing earnings · reciprocal yield 1.2%
PEG ratio
1.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.8×
reciprocal yield 14.8%
P / book
5.6
reciprocal yield 17.9%
FCF yield
3.0%
TTM · current market cap
Buyback yield
—
P / FCF
33.6
reciprocal yield 3.0%
P / operating cash flow
29.7
reciprocal yield 3.4%
Earnings yield
1.2%
Historical valuation
8 metricsP / E historical average (3Y)
955.3×
reciprocal yield 0.1%
P / E historical average (5Y)
955.3×
reciprocal yield 0.1%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-30
Profitability
9 metricsGross margin
74.6%
Operating margin
6.0%
Trailing 12 months
Net margin
7.9%
Gross profit (TTM)
$228.38M
Operating profit (TTM)
$18.23M
Net income (TTM)
$24.22M
Trailing 12 months
Diluted EPS (TTM)
$0.48
FCF margin
20.1%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+22.5%
Year over year
Net income growth YoY
+59.4%
Revenue (TTM)
$306.30M
Trailing 12 months
EPS growth YoY
+60.0%
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+18.9%
Revenue CAGR (5Y)
+17.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+39.8%
FCF CAGR (3Y)
+34.9%
FCF CAGR (5Y)
+10.6%
Quality
14 metricsReturn on equity
6.5%
Return on assets
4.8%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
$31.15M
Free cash flow (TTM)
$61.66M
Quick ratio
4.7
Interest coverage
28.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$125.36M
Total assets
$502.87M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$69.67M
Capital expenditures (TTM)
$8.01M
R&D (TTM)
$29.17M
SG&A (TTM)
$180.98M
Stock compensation (TTM)
$37.50M
R&D / revenue
9.5%
Stock compensation / revenue
12.2%
Ownership (13F)
3 metrics13F filers
318
13F filer change QoQ
+37
Institutional ownership
108.1%
Short interest
3 metricsShort interest
9.2%
Latest settlement · 11.5 days to cover
Days to cover
11.5d
Short-squeeze score
64 / 100
Insider activity
2 metricsNet insider buying (90D)
−$3.49M
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
887359
CUSIP
92346J108
13F (30d)
233 filings
224 filers
Visit website
Investor relations